Journal Title：Eye

Eye seeks to provide the international practising ophthalmologist with high quality articles, of academic rigour, on the latest global clinical and laboratory based research. Its core aim is to advance the science and practice of ophthalmology with the latest clinical- and scientific-based research. Whilst principally aimed at the practising clinician, the journal contains material of interest to a wider readership including optometrists, orthoptists, other health care professionals and research workers in all aspects of the field of visual science worldwide. Eye is the official journal of The Royal College of Ophthalmologists.

Eye encourages the submission of original articles covering all aspects of ophthalmology including: external eye disease; oculo-plastic surgery; orbital and lacrimal disease; ocular surface and corneal disorders; paediatric ophthalmology and strabismus; glaucoma; medical and surgical retina; neuro-ophthalmology; cataract and refractive surgery; ocular oncology; ophthalmic pathology; ophthalmic genetics.

Eye 致力于為國際執業眼科醫生提供高質量的文章，這些文章具有學術嚴謹性，涉及最新的全球臨床和實驗室研究。其核心目標是利用最新的臨床和科學研究推動眼科學和實踐的發展。雖然該期刊主要針對執業臨床醫生，但它包含的材料引起了更廣泛讀者的興趣，包括驗光師、斜視矯正師、其他醫療保健專業人員以及全球視覺科學領域各個方面的研究人員。Eye 是皇家眼科學院的官方期刊。

Eye 鼓勵提交原創文章，涵蓋眼科的各個方面，包括：外眼疾病；眼整形手術；眼眶和淚腺疾病；眼表和角膜疾病；兒科眼科和斜視；青光眼；醫學和外科視網膜；神經眼科；白內障和屈光手術；眼腫瘤學；眼科病理學；眼科遺傳學。

Eye創刊于1987年，由Springer Nature出版商出版，收稿方向涵蓋醫學 - 眼科學全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 一般,3-6周 ，影響因子指數2.8，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。